Company / Cash per Share
Stoke Therapeutics, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.56
FY2025
5-year range
$1.56 / $4.85
FY2021-FY2025
Trend
-44.1%
vs FY2024
Sector context
#125 of 205
Health Care
What the data says
At $1.56, Stoke Therapeutics, Inc.'s cash per share ranks #125 of 205 in the Health Care sector. Declined from $4.85 to $1.56 over the past 2 years.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of -28.9%.
Declined from $4.85 to $1.56 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -20.3%
- 5-Year CAGR
- -28.9%
- 10-Year CAGR
- -
Sector benchmark
#125 of 205 in Health CareTop 61% of 205This company $1.56 Sector average $72.93
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 44.1% year-over-year.
- Ranks #125 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | -44.1% |
| FY2024 | $2.79 | -42.6% |
| FY2023 | $4.85 | +57.7% |
| FY2022 | $3.08 | -22.0% |
| FY2021 | $3.94 | -54.0% |
| FY2020 | $8.58 | -30.7% |
| FY2019 | $12.38 | -91.7% |
| FY2018 | $148.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026